Concepedia

Mitch Raponi

MR

Statistics

Publications

45

Citations

8.7K

H-Index

27

Active since

2000

Affiliations

Clovis Oncology (United States)(Current)

The University of Texas MD Anderson Cancer Center

Johnson & Johnson (United States)

Massachusetts General Hospital

Institut Gustave Roussy

Mitch Raponi is an author at Clovis Oncology (United States) specializing in oncology, medicine, and molecular oncology.

Publications per year

2000–2018

45

Publications

45

Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial

Robert L. Coleman, Amit M. Oza, Domenica Lorusso et al. · The Lancet · 2017 · 1.7K citations · Full text

Medicine, Gynecology, Oncology +12

Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial

Elizabeth M. Swisher, Kevin Lin, Amit M. Oza et al. · The Lancet Oncology · 2016 · 1.2K citations · Full text

Medicine, Oncology, Pharmacology +12

Rociletinib in <i>EGFR</i>-Mutated Non–Small-Cell Lung Cancer

Lecia V. Sequist, Jean‐Charles Soria, Jonathan W. Goldman et al. · New England Journal of Medicine · 2015 · 664 citations · Full text

Medicine, Oncology, Pharmacology +14

Discovery of a Mutant-Selective Covalent Inhibitor of EGFR that Overcomes T790M-Mediated Resistance in NSCLC

Annette O. Walter, Robert Tjin Tham Sjin, Henry J. Haringsma et al. · Cancer Discovery · 2013 · 627 citations · Full text

Medicine, Oncology, Pharmacology +17

Heterogeneity Underlies the Emergence of <i>EGFR</i> T790 Wild-Type Clones Following Treatment of T790M-Positive Cancers with a Third-Generation EGFR Inhibitor

Zofia Piotrowska, Matthew J. Niederst, Chris Karlovich et al. · Cancer Discovery · 2015 · 460 citations · Full text

Medicine, Oncology, Pharmacology +16

1–5 of 45